Waters Co. (NYSE:WAT) Director Christopher A. Kuebler sold 416 shares of the business’s stock in a transaction on Thursday, March 8th. The shares were sold at an average price of $209.00, for a total transaction of $86,944.00. Following the sale, the director now directly owns 15,327 shares of the company’s stock, valued at $3,203,343. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Waters Co. (NYSE:WAT) opened at $212.70 on Monday. Waters Co. has a 1-year low of $153.04 and a 1-year high of $220.20. The company has a debt-to-equity ratio of 0.85, a current ratio of 7.04 and a quick ratio of 6.60. The company has a market cap of $16,757.46, a price-to-earnings ratio of 28.36, a price-to-earnings-growth ratio of 2.55 and a beta of 0.91.
Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, January 23rd. The medical instruments supplier reported $2.51 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.07. Waters had a net margin of 0.88% and a return on equity of 24.70%. The firm had revenue of $687.28 million for the quarter, compared to analyst estimates of $671.98 million. During the same quarter in the previous year, the business posted $2.21 EPS. The firm’s revenue was up 9.3% compared to the same quarter last year. equities analysts expect that Waters Co. will post 8.16 earnings per share for the current fiscal year.
Several analysts have recently issued reports on WAT shares. Zacks Investment Research cut shares of Waters from a “buy” rating to a “hold” rating in a research note on Saturday, January 6th. Barclays reissued a “hold” rating and set a $202.00 price objective on shares of Waters in a research note on Monday, January 8th. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. JPMorgan Chase & Co. upped their price target on shares of Waters from $180.00 to $200.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 24th. Finally, Robert W. Baird upped their price target on shares of Waters from $219.00 to $220.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 24th. Thirteen analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $203.75.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.